Winshell E B, Rosenkranz H S
Department of Microbiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
J Bacteriol. 1970 Dec;104(3):1168-75. doi: 10.1128/jb.104.3.1168-1175.1970.
Nalidixic acid (NAL) is bactericidal for E. coli B. Synthesis of deoxyribonucleic acid (DNA), ribonucleic acid and protein was necessary to initiate the lethal effect, but only protein synthesis was necessary to sustain it. NAL inhibited DNA synthesis specifically, but this inhibition occurred even under conditions that were not lethal to the bacteria. In contrast to other inhibitors of DNA synthesis, NAL did not cause the solubilization of cellular DNA even when bacteria were exposed to it for 2 hr. A bacterial mutant deficient in DNA polymerase was much more sensitive to the lethal action of NAL than its parent strain. Moreover, inhibition of protein synthesis did not protect this mutant from NAL-induced killing. NAL inhibited neither DNA polymerase, nor thymidine or thymidylate kinases. The data are interpretated as suggesting that NAL altered the structure of DNA or a protein attached to nascent DNA and that this lesion can be partially repaired by DNA polymerase.
萘啶酸(NAL)对大肠杆菌B具有杀菌作用。脱氧核糖核酸(DNA)、核糖核酸和蛋白质的合成对于启动致死效应是必需的,但仅蛋白质合成对于维持该效应是必需的。NAL特异性地抑制DNA合成,但这种抑制甚至在对细菌不致死的条件下也会发生。与其他DNA合成抑制剂不同,即使细菌暴露于NAL 2小时,NAL也不会导致细胞DNA溶解。一种缺乏DNA聚合酶的细菌突变体比其亲本菌株对NAL的致死作用更敏感。此外,蛋白质合成的抑制并不能保护该突变体免受NAL诱导的杀伤。NAL既不抑制DNA聚合酶,也不抑制胸苷或胸苷酸激酶。这些数据被解释为表明NAL改变了DNA或附着于新生DNA的蛋白质的结构,并且这种损伤可以被DNA聚合酶部分修复。